Procter & Gamble: Jejurikar proposes $5.52M share sale
The notice also reports a prior sale of 6,176 shares on August 20, 2026, during the preceding three-month period.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Procter & Gamble Co.’s notice identifies Shailesh G. Jejurikar as proposing to sell 35,000 common shares on October 23, 2026, in an exercise-and-sale-of-stock-option transaction through Morgan Stanley Smith Barney LLC. The stated aggregate market value is $5,520,725.00, based on the average of the high and low prices on October 21, 2026. The notice states that the option acquisition and payment dates will be the same.
Key Figures
Key Terms
Rule 144 regulatory
Aggregate market value financial
Exercise and Sale of Stock Option technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What prior stock sale does Shailesh G. Jejurikar’s PG notice report?
AI-generated analysis. How Rhea-AI works. Not financial advice.